Structure

Physi-Chem Properties

Molecular Weight:  476.2
Volume:  464.104
LogP:  1.772
LogD:  1.27
LogS:  -4.254
# Rotatable Bonds:  3
TPSA:  136.43
# H-Bond Aceptor:  9
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.339
Synthetic Accessibility Score:  6.721
Fsp3:  0.76
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.252
MDCK Permeability:  6.127925007604063e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.013
Human Intestinal Absorption (HIA):  0.211
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.716
Plasma Protein Binding (PPB):  50.92223358154297%
Volume Distribution (VD):  0.701
Pgp-substrate:  31.189159393310547%

ADMET: Metabolism

CYP1A2-inhibitor:  0.026
CYP1A2-substrate:  0.904
CYP2C19-inhibitor:  0.028
CYP2C19-substrate:  0.634
CYP2C9-inhibitor:  0.026
CYP2C9-substrate:  0.025
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.088
CYP3A4-inhibitor:  0.674
CYP3A4-substrate:  0.257

ADMET: Excretion

Clearance (CL):  4.62
Half-life (T1/2):  0.511

ADMET: Toxicity

hERG Blockers:  0.04
Human Hepatotoxicity (H-HT):  0.277
Drug-inuced Liver Injury (DILI):  0.744
AMES Toxicity:  0.061
Rat Oral Acute Toxicity:  0.831
Maximum Recommended Daily Dose:  0.283
Skin Sensitization:  0.457
Carcinogencity:  0.188
Eye Corrosion:  0.004
Eye Irritation:  0.012
Respiratory Toxicity:  0.975

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475775

Natural Product ID:  NPC475775
Common Name*:   SGZIVQRVNCEYKD-IFROXHCNSA-N
IUPAC Name:   n.a.
Synonyms:   6Alpha-Tigloyloxychaparrinone
Standard InCHIKey:  SGZIVQRVNCEYKD-IFROXHCNSA-N
Standard InCHI:  InChI=1S/C25H32O9/c1-6-10(2)21(30)34-17-16-11(3)7-14(26)19(29)23(16,5)22-24-9-32-25(22,31)18(28)12(4)13(24)8-15(27)33-20(17)24/h6-7,12-13,16-20,22,28-29,31H,8-9H2,1-5H3/b10-6-/t12-,13+,16-,17-,18-,19-,20-,22-,23-,24-,25+/m1/s1
SMILES:  CC=C(C)C(=O)OC1C2C(=CC(=O)C(C2(C3C45C1OC(=O)CC4C(C(C3(OC5)O)O)C)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL515198
PubChem CID:   44584046
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0002119] Quassinoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. xylem n.a. DOI[10.1248/cpb.24.1532]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[22224661]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[22799262]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[23290052]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota stem barks n.a. n.a. PMID[25666824]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus GI < 0.01 ug ml-1 PMID[473776]
NPT168 Cell Line P388 Mus musculus Activity = 34.0 % PMID[473776]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 16900.0 nM PMID[473777]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 550.0 nM PMID[473777]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 50.0 nM PMID[473777]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475775 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC476529
0.9909 High Similarity NPC107338
0.9909 High Similarity NPC109607
0.9636 High Similarity NPC473968
0.9561 High Similarity NPC470922
0.9455 High Similarity NPC18547
0.9455 High Similarity NPC474906
0.945 High Similarity NPC11252
0.945 High Similarity NPC289312
0.9369 High Similarity NPC152199
0.9369 High Similarity NPC235539
0.9369 High Similarity NPC134869
0.9364 High Similarity NPC51978
0.9358 High Similarity NPC201992
0.9279 High Similarity NPC470919
0.9279 High Similarity NPC469877
0.9273 High Similarity NPC302146
0.9204 High Similarity NPC297179
0.9196 High Similarity NPC474046
0.9196 High Similarity NPC470628
0.9196 High Similarity NPC259306
0.9115 High Similarity NPC473590
0.9083 High Similarity NPC293850
0.906 High Similarity NPC24651
0.9043 High Similarity NPC112038
0.9035 High Similarity NPC188667
0.9035 High Similarity NPC204552
0.9027 High Similarity NPC96312
0.9027 High Similarity NPC40632
0.9027 High Similarity NPC328374
0.9027 High Similarity NPC251236
0.9018 High Similarity NPC49451
0.9 High Similarity NPC143706
0.9 High Similarity NPC472534
0.8974 High Similarity NPC91693
0.8974 High Similarity NPC265557
0.8974 High Similarity NPC105926
0.8974 High Similarity NPC18945
0.8974 High Similarity NPC67251
0.8957 High Similarity NPC122971
0.8957 High Similarity NPC469488
0.8947 High Similarity NPC309433
0.8938 High Similarity NPC473798
0.8926 High Similarity NPC471855
0.8898 High Similarity NPC476729
0.8889 High Similarity NPC312833
0.886 High Similarity NPC474734
0.8818 High Similarity NPC144854
0.8818 High Similarity NPC3316
0.8803 High Similarity NPC470779
0.8803 High Similarity NPC477046
0.8803 High Similarity NPC102822
0.8783 High Similarity NPC470854
0.8783 High Similarity NPC474654
0.8783 High Similarity NPC287343
0.8783 High Similarity NPC97908
0.8783 High Similarity NPC122033
0.877 High Similarity NPC478153
0.877 High Similarity NPC478152
0.877 High Similarity NPC478150
0.8761 High Similarity NPC194951
0.8761 High Similarity NPC474516
0.8761 High Similarity NPC12046
0.876 High Similarity NPC471407
0.875 High Similarity NPC470780
0.8739 High Similarity NPC189075
0.8739 High Similarity NPC154608
0.8739 High Similarity NPC277017
0.8739 High Similarity NPC275539
0.8739 High Similarity NPC192813
0.872 High Similarity NPC596
0.8707 High Similarity NPC251310
0.8707 High Similarity NPC17772
0.8699 High Similarity NPC478151
0.8689 High Similarity NPC25998
0.8689 High Similarity NPC172374
0.8689 High Similarity NPC478155
0.8689 High Similarity NPC329993
0.8689 High Similarity NPC301639
0.8689 High Similarity NPC475377
0.8689 High Similarity NPC45346
0.8689 High Similarity NPC264566
0.8689 High Similarity NPC475167
0.8689 High Similarity NPC478065
0.8689 High Similarity NPC134914
0.8689 High Similarity NPC173435
0.8689 High Similarity NPC262796
0.8689 High Similarity NPC477197
0.8689 High Similarity NPC478064
0.8689 High Similarity NPC476074
0.8684 High Similarity NPC157441
0.8684 High Similarity NPC208998
0.8684 High Similarity NPC25909
0.8684 High Similarity NPC7921
0.8661 High Similarity NPC141350
0.8649 High Similarity NPC110496
0.8644 High Similarity NPC202051
0.864 High Similarity NPC471089
0.864 High Similarity NPC190065
0.864 High Similarity NPC141215
0.8632 High Similarity NPC9674
0.8632 High Similarity NPC470777
0.8632 High Similarity NPC77689
0.8632 High Similarity NPC19028
0.8632 High Similarity NPC473636
0.8621 High Similarity NPC134430
0.8621 High Similarity NPC474483
0.8621 High Similarity NPC176513
0.8621 High Similarity NPC470775
0.8618 High Similarity NPC478154
0.8609 High Similarity NPC243354
0.8607 High Similarity NPC477079
0.8607 High Similarity NPC477076
0.8607 High Similarity NPC477196
0.8607 High Similarity NPC477077
0.8607 High Similarity NPC470913
0.8596 High Similarity NPC269530
0.8584 High Similarity NPC83005
0.8584 High Similarity NPC5103
0.8571 High Similarity NPC295885
0.8571 High Similarity NPC140045
0.856 High Similarity NPC262813
0.8559 High Similarity NPC48692
0.8559 High Similarity NPC102352
0.8548 High Similarity NPC168879
0.8547 High Similarity NPC470776
0.8534 High Similarity NPC471816
0.8534 High Similarity NPC44170
0.8534 High Similarity NPC268954
0.8525 High Similarity NPC477191
0.8525 High Similarity NPC311534
0.8525 High Similarity NPC473620
0.8525 High Similarity NPC477075
0.8525 High Similarity NPC245094
0.8525 High Similarity NPC475281
0.8525 High Similarity NPC477193
0.8525 High Similarity NPC329923
0.8525 High Similarity NPC477192
0.8525 High Similarity NPC477078
0.8525 High Similarity NPC477194
0.8522 High Similarity NPC194273
0.8522 High Similarity NPC255017
0.8522 High Similarity NPC469496
0.8522 High Similarity NPC311592
0.8522 High Similarity NPC469454
0.8522 High Similarity NPC469463
0.8522 High Similarity NPC75167
0.8509 High Similarity NPC146945
0.8509 High Similarity NPC171888
0.8509 High Similarity NPC471243
0.85 High Similarity NPC227397
0.8496 Intermediate Similarity NPC27814
0.8492 Intermediate Similarity NPC251998
0.8487 Intermediate Similarity NPC476204
0.8487 Intermediate Similarity NPC170084
0.8482 Intermediate Similarity NPC230541
0.8475 Intermediate Similarity NPC211093
0.8475 Intermediate Similarity NPC473839
0.8475 Intermediate Similarity NPC127530
0.8475 Intermediate Similarity NPC475041
0.8475 Intermediate Similarity NPC473920
0.8475 Intermediate Similarity NPC470914
0.8468 Intermediate Similarity NPC46823
0.8468 Intermediate Similarity NPC178264
0.8468 Intermediate Similarity NPC102316
0.8468 Intermediate Similarity NPC30279
0.8468 Intermediate Similarity NPC476776
0.8468 Intermediate Similarity NPC277212
0.8468 Intermediate Similarity NPC477195
0.8468 Intermediate Similarity NPC71391
0.8468 Intermediate Similarity NPC192765
0.8468 Intermediate Similarity NPC473918
0.8462 Intermediate Similarity NPC470778
0.8462 Intermediate Similarity NPC146432
0.8462 Intermediate Similarity NPC475809
0.8462 Intermediate Similarity NPC13713
0.8462 Intermediate Similarity NPC284068
0.8455 Intermediate Similarity NPC476966
0.8455 Intermediate Similarity NPC88311
0.8455 Intermediate Similarity NPC82380
0.8455 Intermediate Similarity NPC97918
0.8455 Intermediate Similarity NPC115656
0.8455 Intermediate Similarity NPC305793
0.8455 Intermediate Similarity NPC244296
0.8455 Intermediate Similarity NPC141600
0.8455 Intermediate Similarity NPC11577
0.8455 Intermediate Similarity NPC273878
0.8455 Intermediate Similarity NPC280029
0.8455 Intermediate Similarity NPC470518
0.8455 Intermediate Similarity NPC1314
0.8455 Intermediate Similarity NPC472267
0.8455 Intermediate Similarity NPC252657
0.8455 Intermediate Similarity NPC9470
0.8455 Intermediate Similarity NPC107536
0.8455 Intermediate Similarity NPC269484
0.8455 Intermediate Similarity NPC252289
0.8455 Intermediate Similarity NPC470912
0.8448 Intermediate Similarity NPC102088
0.8448 Intermediate Similarity NPC178289
0.8448 Intermediate Similarity NPC110861

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475775 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8407 Intermediate Similarity NPD6686 Approved
0.8211 Intermediate Similarity NPD7507 Approved
0.8197 Intermediate Similarity NPD8328 Phase 3
0.8016 Intermediate Similarity NPD7319 Approved
0.7984 Intermediate Similarity NPD7492 Approved
0.7966 Intermediate Similarity NPD6882 Approved
0.7966 Intermediate Similarity NPD8297 Approved
0.7951 Intermediate Similarity NPD6054 Approved
0.7951 Intermediate Similarity NPD6319 Approved
0.7937 Intermediate Similarity NPD7736 Approved
0.7931 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.792 Intermediate Similarity NPD6616 Approved
0.7899 Intermediate Similarity NPD4632 Approved
0.7863 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7863 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7078 Approved
0.7851 Intermediate Similarity NPD7115 Discovery
0.7851 Intermediate Similarity NPD6009 Approved
0.7851 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7845 Intermediate Similarity NPD6412 Phase 2
0.7823 Intermediate Similarity NPD6370 Approved
0.7805 Intermediate Similarity NPD6059 Approved
0.7778 Intermediate Similarity NPD6881 Approved
0.7778 Intermediate Similarity NPD6899 Approved
0.7759 Intermediate Similarity NPD5739 Approved
0.7759 Intermediate Similarity NPD7128 Approved
0.7759 Intermediate Similarity NPD6675 Approved
0.7759 Intermediate Similarity NPD6402 Approved
0.7742 Intermediate Similarity NPD6015 Approved
0.7742 Intermediate Similarity NPD6016 Approved
0.7731 Intermediate Similarity NPD6649 Approved
0.7731 Intermediate Similarity NPD6650 Approved
0.7724 Intermediate Similarity NPD7516 Approved
0.7717 Intermediate Similarity NPD8293 Discontinued
0.7712 Intermediate Similarity NPD6373 Approved
0.7712 Intermediate Similarity NPD6372 Approved
0.7699 Intermediate Similarity NPD7638 Approved
0.7699 Intermediate Similarity NPD4225 Approved
0.7692 Intermediate Similarity NPD5697 Approved
0.768 Intermediate Similarity NPD5988 Approved
0.7647 Intermediate Similarity NPD7290 Approved
0.7647 Intermediate Similarity NPD6883 Approved
0.7647 Intermediate Similarity NPD7102 Approved
0.7647 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7642 Intermediate Similarity NPD7327 Approved
0.7642 Intermediate Similarity NPD7328 Approved
0.7632 Intermediate Similarity NPD7640 Approved
0.7632 Intermediate Similarity NPD7639 Approved
0.7627 Intermediate Similarity NPD7320 Approved
0.76 Intermediate Similarity NPD8515 Approved
0.76 Intermediate Similarity NPD7503 Approved
0.76 Intermediate Similarity NPD8033 Approved
0.76 Intermediate Similarity NPD8513 Phase 3
0.76 Intermediate Similarity NPD8516 Approved
0.76 Intermediate Similarity NPD8517 Approved
0.7583 Intermediate Similarity NPD6617 Approved
0.7583 Intermediate Similarity NPD6847 Approved
0.7583 Intermediate Similarity NPD8130 Phase 1
0.7583 Intermediate Similarity NPD6869 Approved
0.7563 Intermediate Similarity NPD6013 Approved
0.7563 Intermediate Similarity NPD6014 Approved
0.7563 Intermediate Similarity NPD6012 Approved
0.7542 Intermediate Similarity NPD5701 Approved
0.752 Intermediate Similarity NPD8377 Approved
0.752 Intermediate Similarity NPD8294 Approved
0.748 Intermediate Similarity NPD7604 Phase 2
0.7479 Intermediate Similarity NPD6011 Approved
0.746 Intermediate Similarity NPD8380 Approved
0.746 Intermediate Similarity NPD8378 Approved
0.746 Intermediate Similarity NPD8379 Approved
0.746 Intermediate Similarity NPD5983 Phase 2
0.746 Intermediate Similarity NPD8335 Approved
0.746 Intermediate Similarity NPD8296 Approved
0.7459 Intermediate Similarity NPD8133 Approved
0.7438 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7395 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7387 Intermediate Similarity NPD6698 Approved
0.7387 Intermediate Similarity NPD46 Approved
0.7364 Intermediate Similarity NPD6336 Discontinued
0.7355 Intermediate Similarity NPD4634 Approved
0.735 Intermediate Similarity NPD5211 Phase 2
0.7348 Intermediate Similarity NPD7260 Phase 2
0.7345 Intermediate Similarity NPD7748 Approved
0.7328 Intermediate Similarity NPD5285 Approved
0.7328 Intermediate Similarity NPD5286 Approved
0.7328 Intermediate Similarity NPD4696 Approved
0.7323 Intermediate Similarity NPD6921 Approved
0.7321 Intermediate Similarity NPD7515 Phase 2
0.7311 Intermediate Similarity NPD6008 Approved
0.7304 Intermediate Similarity NPD7902 Approved
0.7304 Intermediate Similarity NPD4755 Approved
0.7295 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7252 Intermediate Similarity NPD6033 Approved
0.7227 Intermediate Similarity NPD5141 Approved
0.7217 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD5221 Approved
0.7217 Intermediate Similarity NPD5222 Approved
0.7203 Intermediate Similarity NPD5224 Approved
0.7203 Intermediate Similarity NPD4633 Approved
0.7203 Intermediate Similarity NPD5225 Approved
0.7203 Intermediate Similarity NPD5226 Approved
0.72 Intermediate Similarity NPD6274 Approved
0.7179 Intermediate Similarity NPD4700 Approved
0.7176 Intermediate Similarity NPD8074 Phase 3
0.7168 Intermediate Similarity NPD6079 Approved
0.7165 Intermediate Similarity NPD7100 Approved
0.7165 Intermediate Similarity NPD7101 Approved
0.7164 Intermediate Similarity NPD6845 Suspended
0.7155 Intermediate Similarity NPD5173 Approved
0.7155 Intermediate Similarity NPD6083 Phase 2
0.7155 Intermediate Similarity NPD6084 Phase 2
0.7143 Intermediate Similarity NPD5175 Approved
0.7143 Intermediate Similarity NPD5328 Approved
0.7143 Intermediate Similarity NPD5174 Approved
0.7119 Intermediate Similarity NPD5344 Discontinued
0.7119 Intermediate Similarity NPD5223 Approved
0.7117 Intermediate Similarity NPD3573 Approved
0.7107 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6399 Phase 3
0.7097 Intermediate Similarity NPD6053 Discontinued
0.7087 Intermediate Similarity NPD6335 Approved
0.7069 Intermediate Similarity NPD4697 Phase 3
0.7063 Intermediate Similarity NPD6868 Approved
0.7059 Intermediate Similarity NPD7632 Discontinued
0.7049 Intermediate Similarity NPD4729 Approved
0.7049 Intermediate Similarity NPD4730 Approved
0.7043 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD7900 Approved
0.7025 Intermediate Similarity NPD4768 Approved
0.7025 Intermediate Similarity NPD4767 Approved
0.7008 Intermediate Similarity NPD6317 Approved
0.6953 Remote Similarity NPD6313 Approved
0.6953 Remote Similarity NPD6314 Approved
0.6947 Remote Similarity NPD6067 Discontinued
0.6937 Remote Similarity NPD1694 Approved
0.6935 Remote Similarity NPD5250 Approved
0.6935 Remote Similarity NPD6371 Approved
0.6935 Remote Similarity NPD5247 Approved
0.6935 Remote Similarity NPD5251 Approved
0.6935 Remote Similarity NPD5249 Phase 3
0.6935 Remote Similarity NPD5248 Approved
0.6923 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6908 Approved
0.6923 Remote Similarity NPD6909 Approved
0.6911 Remote Similarity NPD5128 Approved
0.6903 Remote Similarity NPD5737 Approved
0.6903 Remote Similarity NPD6672 Approved
0.6875 Remote Similarity NPD3618 Phase 1
0.687 Remote Similarity NPD6411 Approved
0.686 Remote Similarity NPD4754 Approved
0.6838 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6838 Remote Similarity NPD5695 Phase 3
0.6818 Remote Similarity NPD4752 Clinical (unspecified phase)
0.681 Remote Similarity NPD5778 Approved
0.681 Remote Similarity NPD5779 Approved
0.6807 Remote Similarity NPD5696 Approved
0.6807 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6783 Remote Similarity NPD7838 Discovery
0.6754 Remote Similarity NPD7513 Clinical (unspecified phase)
0.675 Remote Similarity NPD6648 Approved
0.6746 Remote Similarity NPD5216 Approved
0.6746 Remote Similarity NPD5215 Approved
0.6746 Remote Similarity NPD5217 Approved
0.6726 Remote Similarity NPD6684 Approved
0.6726 Remote Similarity NPD7334 Approved
0.6726 Remote Similarity NPD6409 Approved
0.6726 Remote Similarity NPD7521 Approved
0.6726 Remote Similarity NPD5330 Approved
0.6726 Remote Similarity NPD7146 Approved
0.6724 Remote Similarity NPD7983 Approved
0.6724 Remote Similarity NPD5693 Phase 1
0.6714 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6696 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6696 Remote Similarity NPD4786 Approved
0.6696 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6696 Remote Similarity NPD4753 Phase 2
0.6696 Remote Similarity NPD6101 Approved
0.6667 Remote Similarity NPD4202 Approved
0.6667 Remote Similarity NPD5169 Approved
0.6667 Remote Similarity NPD3667 Approved
0.6667 Remote Similarity NPD5135 Approved
0.6667 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6643 Remote Similarity NPD8387 Clinical (unspecified phase)
0.6642 Remote Similarity NPD5956 Approved
0.664 Remote Similarity NPD5168 Approved
0.6636 Remote Similarity NPD4695 Discontinued
0.6625 Remote Similarity NPD7799 Discontinued
0.6614 Remote Similarity NPD5127 Approved
0.661 Remote Similarity NPD5282 Discontinued
0.6609 Remote Similarity NPD6903 Approved
0.6581 Remote Similarity NPD8035 Phase 2
0.6581 Remote Similarity NPD8034 Phase 2
0.6571 Remote Similarity NPD8415 Approved
0.6555 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6555 Remote Similarity NPD5210 Approved
0.6555 Remote Similarity NPD4629 Approved
0.6554 Remote Similarity NPD7236 Approved
0.6552 Remote Similarity NPD6904 Approved
0.6552 Remote Similarity NPD6673 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data